Related Experiment Videos

Major bacterial infections following liver transplantation: a prospective study

C Lumbreras1, M Lizasoain, E Moreno

  • 1Infectious Diseases and Microbiology Department, Hospital 12 De Octubre, Madrid, Spain.

Insights

Major bacterial infections are common after liver transplantation (LT), affecting 64% of patients. Gram-positive bacteria were the most frequent cause, highlighting the need for targeted prevention and treatment strategies.

Area of Science:

  • Infectious Diseases
  • Transplantation Medicine
  • Bacteriology

Background:

  • Liver transplantation (LT) is a complex procedure associated with significant risks.
  • Postoperative infections, particularly bacterial infections, contribute substantially to morbidity and mortality in LT recipients.

Purpose of the Study:

  • To prospectively investigate the incidence and characteristics of major bacterial infections following liver transplantation.
  • To identify the primary sources, causative microorganisms, and clinical presentations of these infections.

Main Methods:

  • Prospective study of 50 consecutive adult liver transplant patients.
  • Standardized immunosuppression, antibiotic prophylaxis, and selective bowel decontamination (SBD) protocols were used.
  • Detailed monitoring for infectious episodes, including clinical presentation, microbiology, and outcomes.

Main Results:

  • 64% of patients experienced at least one major bacterial infection within the first two months post-LT.
  • Bacteremia, pneumonia, and abdominal abscesses were the most common presentations.
  • Gram-positive bacteria (69%) predominated, with intravascular catheters frequently identified as the source of bacteremia.
  • One death was directly attributed to bacterial infection, representing 13% of postoperative mortality.

Conclusions:

  • Major bacterial infections pose a significant threat to liver transplant recipients, impacting both morbidity and mortality.
  • The predominance of Gram-positive infections may be linked to selective bowel decontamination (SBD) with norfloxacin.
  • Improved strategies for infection prevention, source identification, and targeted treatment are crucial for enhancing patient outcomes.

Related Concept Videos